The North America Retinal Imaging Devices Market would witness market growth of 6.3% CAGR during the forecast period (2019-2025).
North America captured a substantial share of the overall market for retinal imaging devices in 2018. The high prevalence of ophthalmic disorders, the increased rate of adoption of advanced technology, as well as the presence of a large number of global players in the market are factors that contribute to the dominant market share.
The retina is a sensory membrane found behind the eyeball. It consists of several complex layers and cells known as photoreceptors. The human eye has two forms of photo-receptors: rod and cone. Rod photoreceptor cells sense motion and differentiate between black and white visions, and provide low light vision. Cone photoreceptors identify the colors in bright and medium light and provide vision.
Cones are placed in the small concentrated area of the retina, whilst rods are placed throughout the retina. When the cornea and lens direct the light through the optic nerve to the photoreceptor cells, the light energy gets converted into chemical energy and passed to the brain. Some of the common retinal ailments are diabetic retinopathy, macular edema, macular degeneration, solar retinopathy, central serious retinopathy, etc. The fundus camera provides this device with various advantages, such as portability and ergonomics. Additionally, the growing number of fundus cameras installations with an increased number of ophthalmic clinics and outpatient eye care centers is estimated to drive market growth.
Based on Type, the market is segmented into Fundus Camera, Fluorescein Angiography and OCT (Optical Coherence Tomography). Based on End Use, the market is segmented into Hospitals, Ophthalmic Centers, ASCs (Ambulatory Surgery Centers) and Other End Use. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Topcon Corporation, Carl Zeiss AG, Olympus Corporation, Robert Bosch GmbH (Bosch Healthcare), Revenio Group Oyj (CenterVue SpA), Nikon Corporation (Optos PLC), Optomed PLC, Epipole Ltd., Nidek Co., Ltd., and Eyenuk, Inc.
Scope of the Study
Market Segmentation:
By Type

  • Fundus Camera
  • Fluorescein Angiography
  • OCT (Optical Coherence Tomography)


By End Use

  • Hospitals
  • Ophthalmic Centers
  • ASCs (Ambulatory Surgery Centers)
  • Other End Use


By Country

  • US
  • Canada
  • Mexico
  • Rest of North America


Companies Profiled

  • Topcon Corporation
  • Carl Zeiss AG
  • Olympus Corporation
  • Robert Bosch GmbH (Bosch Healthcare)
  • Revenio Group Oyj (CenterVue SpA)
  • Nikon Corporation (Optos PLC)
  • Optomed PLC
  • Epipole Ltd.
  • Nidek Co., Ltd.
  • Eyenuk, Inc


Unique Offerings from KBV Research

  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free